Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis

NCT01124838 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

261

Enrollment

INDUSTRY

Sponsor class

Conditions

Uveitis

Interventions

DRUG: Adalimumab
DRUG: Prednisone
DRUG: Placebo

Sponsor

AbbVie (prior sponsor, Abbott)